EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Taekyung Chem (006890) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Taekyung Chem KRW 11,265, price KRW 4,940, upside +128.0%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Utilities · KR · ISIN KR7006890008

TC Some data Sep 24, 2026

Taekyung Chem

006890 · KO

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value 11,265 KRW · Strongly undervalued (+128%)
!Quality 41/100
!Expensive Growth (revenue 5y +5.4 %/yr)
✓Solidly profitable · 13.8% net margin (TTM)
!Low debt · negative free cash flow
·3.64% dividend yield
!Trails peers (3/10)
!Narrow moat 35/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 20 out of 100
Watch Taekyung Chem for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

19,345 KRW 4,940 KRW Fair Value 11,265 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 4,940 KRW – 19,345 KRW · fair‑value band 9,840 KRW – 13,749 KRW · the 4,940 KRW price screens below the 11,265 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Taekyung Chem in your weekly email

Every Wednesday you see whether Taekyung Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Taekyung Chemical Co., Ltd. manufactures and sells liquid and solid carbon dioxide and dry ice in Korea. The company offers magnesium hydroxide, ethylene, liquid oxygen, liquid nitrogen, and argon.

Show more

Taekyung Chemical Co., Ltd. manufactures and sells liquid and solid carbon dioxide and dry ice in Korea. The company offers magnesium hydroxide, ethylene, liquid oxygen, liquid nitrogen, and argon. Its products are primarily used in industry, food and beverage, medicine, fresh food delivery, quick freezing, cooling, blast cleaning, food preservation, deflashing, cryogenic grinding, welding, desulfurization, and neutralization, as well as fog effect for event. The company was formerly known as Daeduk Industry Co., Ltd. and changed its name to Taekyung Chemical Co., Ltd. in 2000. Taekyung Chemical Co., Ltd. was founded in 1970 and is headquartered in Seoul, South Korea.

Stock analysis

Taekyung Chem (006890) currently trades at 4,940 KRW, while our model-based Fair Value estimate is 11,265 KRW, implying the stock looks roughly 56.1% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 13,120 KRW per share, and 7 of the 9 models we run sit above the 4,940 KRW price.

Bear case: the Earnings-Based group reads lowest at 8,799 KRW, and 2 of the 9 models stay below the price. Evidence for this calculation is medium.

Scenario range: 9,840 KRW (bear) to 13,749 KRW (bull), the price of 4,940 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Utilities sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Taekyung Chem reported revenue of 61.3B KRW in FY2025 versus 54.1B KRW in FY2021, a compound +3.2%/yr. Reported net income was 8.7B KRW in FY2025, compounding −5.4%/yr from FY2021.

Key figures

Market cap 63.6B KRW (≈ $46.7M) · P/S ratio 1.07 · Dividend yield 3.6% · Net margin 14.3% · Return on equity 4.9% · Return on assets (EBIT) 6.4% · Operating margin −4.7% · Revenue (TTM) 59.5B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).

What moves the price

The share trades about 54% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Utilities peers we cover trades at −11% fair-value upside, at 128%, 006890 screens cheaper than that median.

Fair Value models

Bear 9,840 KRW Fair Value 11,265 KRW Bull 13,749 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income 11,512 KRW 11,582 KRW 10,915 KRW 76
Graham-Dodd 5,248 KRW 8,799 KRW 10,703 KRW 67
Growth-Adj P/E 7,403 KRW 10,576 KRW 13,749 KRW 67
All 10 models by family
Earnings-Based
Graham-Dodd 5,248 KRW 8,799 KRW 10,703 KRW 67
Multiples
P/E Multiple 10,419 KRW 13,891 KRW 17,364 KRW 63
P/S Multiple 9,840 KRW 13,120 KRW 16,400 KRW 58
P/B Multiple 9,840 KRW 13,120 KRW 16,400 KRW 55
EV/EBIT n/a 84.52 KRW 767.22 KRW 61
EV/EBITDA 367.57 KRW 1,372 KRW 2,377 KRW 61
EV/Revenue n/a n/a 430.42 KRW 50
Asset-Based
NCAV (Graham) 7,612 KRW 10,201 KRW 15,225 KRW 54
Economic Profit
Residual Income 11,512 KRW 11,582 KRW 10,915 KRW 76
Growth Earnings
Growth-Adj P/E 7,403 KRW 10,576 KRW 13,749 KRW 67

Open the full fair value analysis →

Notify me when 006890 reaches fair value

Put 006890 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 41/100

Of which business quality 42 · Market factors (momentum, volatility) 23

Profitability 31
Margins and returns on capital today
Quality Growth 15
Are margins and returns improving?
Cashflow 17
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 41
Disciplined investing over empire-building
Low Volatility 67
Calm price path (market factor)
Momentum 7
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−13.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Start year 2020 (pandemic). Over 10 years: +1.9% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+1.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−2.1%
Dividend (yield on the price)3.6%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 3%

Watch 006890, get fair value alerts →

Compare Taekyung Chem with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Utilities - Regulated Gas · 107 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside +128% · Top 25%
Profitability
Return on equity (TTM) 5% · Bottom 25%
Return on assets 0% · Bottom 25%
Net margin (TTM) 14% · Top 25%
Operating margin (TTM) −5% · Bottom 25%
Growth and dividend
Revenue growth −12% · Bottom 25%
Dividend yield (TTM) 3.6% · Below median
Balance sheet
Debt / equity 0.23× · Below median

Valuation Multiplesvs Utilities - Regulated Gas median · lower = cheaper

EV/EBITDA 10.4× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 38
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)20 · sector 35
HEALTH (low debt)88 · sector 83
DIVIDEND (yield)73 · sector 73

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Utilities - Regulated Gas stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Naturgy Energy Group NTGY €29.48 €32.79 +11%
Atmos Energy Corporation ATO $156.24 $77.92 −50%
NiSource Inc NI $39.25 $19.90 −49%
Uniper SE UN0 €48.45 €45.97 −5%
The Hong Kong and China Gas Company 0003 HK$7.12 HK$4.79 −33%
GAIL (India) Limited GAIL ₹172.95 ₹132.19 −24%
Italgas S.p.A IG €8.43 €9.27 +10%
ENN Natural Gas Co 600803 ¥18.58 ¥61.20 +229%
UGI Corporation UGI $36.85 $32.82 −11%
Southwest Gas Holdings SWX $83.49 $57.83 −31%

Explore undervalued stocks

More undervalued Utilities stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Taekyung Chem · Fair Value
11,265 KRW +56%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Taekyung Chem Fair Value". https://www.fairvalue-calculator.com/stock/006890

Frequently asked questions

Is Taekyung Chem (006890) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 11,265 KRW versus a price of 4,940 KRW, about +128% upside (undervalued).
What is the fair value of 006890?
Our model-based fair value for Taekyung Chem is 11,265 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 4,940 KRW.
What is the quality score of 006890?
Taekyung Chem has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Taekyung Chem (006890)?
Our model-based price target is the fair value of 11,265 KRW (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 9,840 KRW, optimistic scenario 13,749 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Taekyung Chem stock forecast for 2026?
Our models put fair value at 11,265 KRW, about +128% upside versus a price of 4,940 KRW (undervalued). Cautious scenario 9,840 KRW, optimistic scenario 13,749 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Taekyung Chem (006890)?
Taekyung Chem reported trailing-twelve-month revenue of about 59.5B KRW (latest available figure, as of Sep 24, 2026).
Does Taekyung Chem pay a dividend?
Taekyung Chem currently shows a dividend yield of about 3.64% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Taekyung Chem (006890)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Taekyung Chem it is 11,265 KRW per share (as of Sep 24, 2026), against a price of 4,940 KRW. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Taekyung Chem stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 006890 trades below its calculated fair value: price 4,940 KRW, fair value 11,265 KRW, a gap of about +128% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 006890?
No. The price is what the market pays today (4,940 KRW); the fair value is what the company's own numbers justify (11,265 KRW). For Taekyung Chem the two are 6,325 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Taekyung Chem worth?
The market values Taekyung Chem at about 63.6B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 4,940 KRW; our models calculate a fair value of 11,265 KRW per share.
What do the bullish and bearish scenarios say about 006890?
Our models span a range for Taekyung Chem: cautious scenario 9,840 KRW, base 11,265 KRW, optimistic 13,749 KRW per share (as of Sep 24, 2026, price 4,940 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Taekyung Chem (006890)?
Balance-sheet figures for Taekyung Chem (as of Sep 24, 2026): return on equity 4.9%, debt of 0.23 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is 006890 from its 52-week high?
Taekyung Chem trades at 4,940 KRW, about 54% below its 52-week high of 10,680 KRW and at the low of 4,940 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 11,265 KRW is for.
Which stocks are comparable to Taekyung Chem?
From the same area (Utilities) we also value Naturgy Energy Group, Atmos Energy Corporation, NiSource Inc, Uniper SE, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Taekyung Chem stock attractive at the current price?
The data as of Sep 24, 2026: price 4,940 KRW, calculated fair value 11,265 KRW (+128%), Quality Score 41/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 006890 calculated?
We run Taekyung Chem through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 11,265 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Taekyung Chem currently trades 128 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Taekyung Chem (006890)?
The closing price on Sep 23, 2026 was 4,940 KRW. Our model-based fair value is 11,265 KRW, about +128% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Taekyung Chem right now?
The large discount to fair value meets weak quality (41/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (9,840 KRW). The market is more pessimistic than our downside scenario.

Key figures of Taekyung Chem

How large is the market capitalisation of Taekyung Chem (006890)?
The market capitalisation of Taekyung Chem is 63.6B KRW (≈ $46.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Taekyung Chem (006890)?
The price-to-sales ratio of Taekyung Chem is 1.07 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Taekyung Chem (006890)?
The dividend yield of Taekyung Chem is 3.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Taekyung Chem (006890)?
The net margin of Taekyung Chem is 14.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Taekyung Chem (006890)?
The return on equity (ROE) of Taekyung Chem is 4.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Taekyung Chem (006890)?
On an EBIT basis the return on assets of Taekyung Chem is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Taekyung Chem (006890)?
The operating margin of Taekyung Chem is −4.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Taekyung Chem (006890)?
Revenue at Taekyung Chem is growing −11.5% versus a year earlier (3y avg +1.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Taekyung Chem (006890)?
Earnings per share at Taekyung Chem are growing −24.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Taekyung Chem (006890) generate?
The free cash flow of Taekyung Chem is −7.8B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Taekyung Chem (006890) carry?
The net debt of Taekyung Chem is 30.0B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Taekyung Chem in the live analysis

One click puts Taekyung Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.